MARÍA INMACULADA
JIMÉNEZ NACHER
Profesora asociada de Ciencias de la Salud
Instituto de Salud Carlos III
Madrid, EspañaPublications en collaboration avec des chercheurs de Instituto de Salud Carlos III (10)
2011
-
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial
The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283
-
Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients
Journal of Viral Hepatitis, Vol. 18, Núm. 5, pp. 325-330
2009
-
Rate and timing of hepatitis c virus relapse after a successful course of pegylated interferon plus ribavirin in hiv-infected and hiv-uninfected patients
Clinical Infectious Diseases, Vol. 49, Núm. 9, pp. 1397-1401
2003
-
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
AIDS, Vol. 17, Núm. 7, pp. 1023-1028
-
Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α-2b Plus Ribavirin
AIDS Research and Human Retroviruses, Vol. 19, Núm. 12, pp. 1083-1089
2002
-
Liver toxicity caused by nevirapine
AIDS, Vol. 16, Núm. 2, pp. 290-291
2001
-
Higher efavirenz plasma levels correlate with development of insomnia [1]
Journal of Acquired Immune Deficiency Syndromes
1998
-
Eficacia y tolerancia de la combinacion AZT, DDC y saquinavir en pacientes infectados por el virus de la inmunodeficiencia humana
Revista Clinica Espanola
-
Interacciones farmacológicas en los pacientes infectados por el virus de la inmunodeficiencia humana
Revista Clinica Espanola, Vol. 198, Núm. 11, pp. 765-768
-
Virological failure and adherence to antiretroviral therapy in HIV-infected patients [7]
AIDS